These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6713776)

  • 1. Effect of carbohydrates on estimated hepatic blood flow.
    Svensson CK; Mauriello PM; Barde SH; Middleton E; Lalka D
    Clin Pharmacol Ther; 1984 May; 35(5):660-5. PubMed ID: 6713776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of food on hepatic blood flow: implications in the "food effect" phenomenon.
    Svensson CK; Edwards DJ; Mauriello PM; Barde SH; Foster AC; Lanc RA; Middleton E; Lalka D
    Clin Pharmacol Ther; 1983 Sep; 34(3):316-23. PubMed ID: 6883907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of hydralazine, nitroglycerin, and food on estimated hepatic blood flow.
    Svensson CK; Cumella JC; Tronolone M; Middleton E; Lalka D
    Clin Pharmacol Ther; 1985 Apr; 37(4):464-8. PubMed ID: 3919988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Food effects on propranolol systemic and oral clearance: support for a blood flow hypothesis.
    Olanoff LS; Walle T; Cowart TD; Walle UK; Oexmann MJ; Conradi EC
    Clin Pharmacol Ther; 1986 Oct; 40(4):408-14. PubMed ID: 3757404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of posture on hepatic perfusion and the presystemic biotransformation of propranolol: simulation of the food effect.
    Modi MW; Hassett JM; Lalka D
    Clin Pharmacol Ther; 1988 Sep; 44(3):268-74. PubMed ID: 3046813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of hepatic blood flow in healthy subjects by continuous infusion of indocyanine green.
    Soons PA; De Boer A; Cohen AF; Breimer DD
    Br J Clin Pharmacol; 1991 Dec; 32(6):697-704. PubMed ID: 1768562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indocyanine green clearance following single and chronic cimetidine doses.
    MacKichan JJ; Schaal SF; Stine RA; Boudoulas H
    Res Commun Chem Pathol Pharmacol; 1984 May; 44(2):323-6. PubMed ID: 6739959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of moderate haemodilution with Fluosol-DA or normal saline on indocyanine green and (+)-propranolol kinetics.
    Shrewsbury RP; Lewis LM; Oliver SR; Womble CL
    J Pharm Pharmacol; 1987 Aug; 39(8):592-8. PubMed ID: 2888848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased clearance of propranolol and theophylline by high-protein compared with high-carbohydrate diet.
    Fagan TC; Walle T; Oexmann MJ; Walle UK; Bai SA; Gaffney TE
    Clin Pharmacol Ther; 1987 Apr; 41(4):402-6. PubMed ID: 3829577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of propranolol on metabolic activity of the liver in patients with alcoholic cirrhosis.
    Vinel JP; Caucanas JP; Calès P; Suduca JM; Voigt JJ; Pascal JP
    J Hepatol; 1988 Oct; 7(2):186-92. PubMed ID: 3192922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms and variations in the food effect on propranolol bioavailability.
    Liedholm H; Wåhlin-Boll E; Melander A
    Eur J Clin Pharmacol; 1990; 38(5):469-75. PubMed ID: 2379531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Food-induced increase in propranolol bioavailability--relationship to protein and effects on metabolites.
    Walle T; Fagan TC; Walle UK; Oexmann MJ; Conradi EC; Gaffney TE
    Clin Pharmacol Ther; 1981 Dec; 30(6):790-5. PubMed ID: 7307427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enprostil, in contrast to cimetidine, does not inhibit propranolol metabolism.
    Reilly CS; Biollaz J; Koshakji RP; Wood AJ
    Clin Pharmacol Ther; 1986 Jul; 40(1):37-41. PubMed ID: 3087677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of physical exercise on the pharmacokinetics of propranolol.
    Arends BG; Böhm RO; van Kemenade JE; Rahn KH; van Baak MA
    Eur J Clin Pharmacol; 1986; 31(3):375-7. PubMed ID: 3792439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of liver blood flow and propranolol metabolism by cimetidine.
    Feely J; Wilkinson GR; Wood AJ
    N Engl J Med; 1981 Mar; 304(12):692-5. PubMed ID: 7464861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A computer simulation of the food effect: transient changes in hepatic blood flow and Michaelis-Menten parameters as mediators of hepatic first pass metabolism and bioavailability of propranolol.
    Semple HA; Tam YK; Coutts RT
    Biopharm Drug Dispos; 1990; 11(1):61-76. PubMed ID: 2322637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (+)-Propranolol clearance, an estimation of hepatic blood flow in man.
    Weiss YA; Safar ME; Lehner JP; Levenson JA; Simon A; Alexandre JM
    Br J Clin Pharmacol; 1978 May; 5(5):457-60. PubMed ID: 656285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of propranolol on hepatic blood flow in patients with cirrhosis.
    Braillon A; Jirón MI; Valla D; Calès P; Lebrec D
    Clin Pharmacol Ther; 1985 Apr; 37(4):376-80. PubMed ID: 3978998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic study on the hepatic uptake of indocyanine green in cirrhotic patients.
    Kawasaki S; Sugiyama Y; Iga T; Hanano M; Sanjo K; Beppu T; Idezuki Y
    Am J Gastroenterol; 1985 Oct; 80(10):801-6. PubMed ID: 4036939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary thermogenesis in obesity. Response to carbohydrate and protein meals: the effect of beta-adrenergic blockade and semistarvation.
    Zed C; James WP
    Int J Obes; 1986; 10(5):391-405. PubMed ID: 3781724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.